Table II.
Liver inflammation and fibrosis staging scores in the control, BM-MSC and AD-MSC transplanted groups.
| Group | Inflammatory activity | Fibrosis staging score |
|---|---|---|
| Blank control | 13.78±2.53 | 5.09±1.15 |
| Negative control | 13.34±1.89 | 4.95±1.22 |
| BM-MSCs | 9.87±2.07a | 4.17±0.94a |
| AD-MSCs | 10.13±1.81a | 3.98±0.82a |
Data are presented as the mean ± standard deviation. Inflammation and fibrosis scores were evaluated according to the Ishak modified histological activity index (21).
a
P<0.05 vs. controls. BM-MSCs, bone marrow-derived mesenchymal stem cells; AD-MSCs, adipose tissue-derived mesenchymal stem cells.